![Safa'a Al-Rais](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Safa'a Al-Rais
Directeur des opérations chez Resilience Biotechnologies, Inc.
Profil
Safa'a Al-Rais is currently the Chief Operating Officer at Resilience Biotechnologies, Inc. Prior to this, he worked at Therapure Biopharma, Inc. from 2009 to 2020 as the Vice President-Operations.
Postes actifs de Safa'a Al-Rais
Sociétés | Poste | Début |
---|---|---|
Resilience Biotechnologies, Inc.
![]() Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the company is Rahul Singhvi. | Directeur des opérations | - |
Anciens postes connus de Safa'a Al-Rais
Sociétés | Poste | Fin |
---|---|---|
Therapure Biopharma, Inc.
![]() Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Directeur des opérations | 01/10/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Therapure Biopharma, Inc.
![]() Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | Health Technology |
Resilience Biotechnologies, Inc.
![]() Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the company is Rahul Singhvi. | Health Technology |